Vigonvita Life Sciences Co., Ltd.

HK$69.20As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2630Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (General)
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$11.60B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$75
8.35%
(72.86%)
Buy 3|1|8|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.70
0.67
0.71
0.79
4.16%
3.14%
5.85%
24.12%
Revenue¥M
632.6
644.1
656.4
671.5
10.89%
12.57%
8.70%
9.73%
Peers (US$1.479B)
Cap (US$)
PE
1.545B
—
Capital
TTM
5Y
10Y
Leveragex
0.351
0.079
0.053
EBIT/Intx
0.806
0.773
0.704
Own earn%
58.93
28.81
19.14
Sh yield%
30.98
31.77
34.96
Owners
Insiders/Inst%
9.11
44.78
Short interest%
5.82
SBC / revenue%
2.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–8
$1 testx
—
Incr. ROIC%
22